¼¼°èÀÇ ¼Òȱ⠰ü·Ã Á¦Ç° ½ÃÀå : µð¹ÙÀ̽ºº°, Áúȯº°, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(-2029³â)
Gastrointestinal Products Market by Devices (Endoscopy, Ablation system, Motility testing, Biopsy devices, Stenting devices, pH monitoring), Diseases (GERD), (IBD), (Gastrointestinal cancer), End-User (Hospitals, ASC) - Forecast to 2029
»óǰÄÚµå
:
1546369
¸®¼Ä¡»ç
:
MarketsandMarkets
¹ßÇàÀÏ
:
2024³â 08¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 375 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
¼¼°èÀÇ ¼Òȱ⠰ü·Ã Á¦Ç° ½ÃÀå ±Ô¸ð´Â 2024³â 147¾ï ´Þ·¯¿¡¼ 2029³â±îÁö 197¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î Æò°¡µÇ°í, ¿¹Ãø ±â°£ µ¿¾È º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 6.1%ÀÇ ¼ºÀåÀÌ Àü¸ÁµË´Ï´Ù.
½ÃÀåÀº ¼Òȱâ ÁúȯÀÇ ÀÌȯÀ² Áõ°¡, ±â¼ú Çâ»ó, °í·ÉÈ, ÀÇ·áºñ »ó½Â, ÀÎÁöµµ Çâ»ó ¹× ½ºÅ©¸®´× ³ë·Â, ¿¬±¸ °³¹ßºñ Áõ°¡, ¸ÂÃãÇü ÀÇ·á Çʿ伺, ½ÅÈï ½ÃÀå °æÁ¦ Àû È®´ë µîÀÇ ¿äÀο¡ ÀÇÇØ °ßÀεǰí ÀÖ½À´Ï´Ù. ¼Òȱ⠰ü·Ã Á¦Ç° »ê¾÷Àº ÀÌ·¯ÇÑ ¿äÀÎÀÇ º¹ÇÕÀûÀÎ ¿µÇâÀ¸·Î ¿ªµ¿ÀûÀ̰í ÁøÈÇϰí ÀÖ½À´Ï´Ù.
Á¶»ç ¹üÀ§
Á¶»ç ´ë»ó³âµµ
2021³â-2029³â
±âÁسâ
2023³â
¿¹Ãø ±â°£
2024³â-2029³â
´ÜÀ§
10¾ï ´Þ·¯
ºÎ¹®
µð¹ÙÀ̽ºº°, Áúº´º°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°
´ë»ó Áö¿ª
ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
"µð¹ÙÀ̽ºº°·Î ³»½Ã°æ ºÎ¹®Àº ¿¹Ãø ±â°£¿¡ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÕ´Ï´Ù."
³»½Ã°æ ±â¼úÀº Æú¸³ ÀýÁ¦, Á¶Á÷ »ý°Ë, ½ºÅÙÆ® À¯Ä¡, Á¾¾ç ÀýÁ¦ µîÀÇ Ä¡·á ¹× Áø´ÜÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ °³¹ßÀº ´Ù¾çÇÑ ¼Òȱâ Áúȯ¿¡ ´ëÇÑ ³»½Ã°æ °Ë»çÀÇ ÀÌ¿ëÀ» Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù.
"Áúȯº°·Î GERD ºÎ¹®Àº ¿¹Ãø ±â°£¿¡ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÕ´Ï´Ù."
¶óÀÌÇÁ½ºÅ¸ÀÏ ¿äÀÎ, ºñ¸¸, °í·ÉÈ, Áø´Ü/Ä¡·á ¿É¼ÇÀÇ Ãæ½Ç µî¿¡ ÀÇÇÑ GERD À¯º´·ü Áõ°¡°¡ ¼Òȱ⠳»°ú ½ÃÀå Á¡À¯À²À» Å©°Ô ¹Ð¾î ¿Ã¸®°í ÀÖ½À´Ï´Ù. ÀÎÁöµµ Çâ»ó°ú ±â¼ú Áøº¸°¡ °è¼ÓµÊ¿¡ µû¶ó ¼Òȱ⠰ü·Ã Á¦Ç° ¼ºñ½º¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ°í ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¼¼°èÀÇÀûÀÎ ³ëÈ¿¡ µû¶ó GERDÀÇ ÀÌȯÀ²ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. °í·ÉÀÚ´Â ½Äµµ ¿îµ¿°ú ÇϺΠ½Äµµ °ý¾à±ÙÀÇ ±â´ÉÀÌ º¯ÈÇϱ⠶§¹®¿¡ GERD¿¡ °É¸®±â ½¬¿öÁý´Ï´Ù.
"¾Æ½Ã¾ÆÅÂÆò¾çÀÌ ¿¹Ãø ±â°£¿¡ °¡Àå ³ôÀº º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù."
ÀϺ», Çѱ¹, Áß±¹À» Æ÷ÇÔÇÑ ¸¹Àº ¾Æ½Ã¾ÆÅÂÆò¾ç ±¹°¡¿¡¼´Â °í·ÉÈ¿¡ µû¶ó Àα¸ µ¿Å°¡ º¯ÈÇϰí ÀÖ½À´Ï´Ù. ³ëÀÎÀº GERD¿Í °°Àº Áúº´ÀÇ À¯º´·üÀÌ ³ô°í º¹ÀâÇÑ ÀÇ·á ¿ä±¸°¡ ÀÖ½À´Ï´Ù.
ÀÌ º¸°í¼´Â ¼¼°èÀÇ ¼Òȱ⠰ü·Ã Á¦Ç° ½ÃÀå¿¡ ´ëÇÑ Á¶»ç ºÐ¼®À» ÅëÇØ ÁÖ¿ä ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎ, °æÀï ±¸µµ, ¹Ì·¡ µ¿Çâ µîÀÇ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù.
¸ñÂ÷
Á¦1Àå ¼·Ð
Á¦2Àå Á¶»ç ¹æ¹ý
Á¦3Àå ÁÖ¿ä ¿ä¾à
Á¦4Àå Áß¿ä ÀλçÀÌÆ®
¼Òȱ⠰ü·Ã Á¦Ç° ½ÃÀå °³¿ä
¾Æ½Ã¾ÆÅÂÆò¾ç ¼Òȱ⠰ü·Ã Á¦Ç° ½ÃÀå : µð¹ÙÀ̽ºº°, Áö¿ªº°(2023³â)
¼Òȱ⠰ü·Ã Á¦Ç° ½ÃÀåÀÇ Áö¸®Àû ½º³À¼¦
Á¦5Àå ½ÃÀå °³¿ä
¼Ò°³
½ÃÀå ¿ªÇÐ
¼ºÀå ÃËÁø¿äÀÎ
¾ïÁ¦¿äÀÎ
±âȸ
°úÁ¦
»ê¾÷ µ¿Çâ
±â¼ú ºÐ¼®
ÁÖ¿ä ±â¼ú
º¸¿Ï ±â¼ú
ÀÎÁ¢ ±â¼ú
¹ë·ùüÀÎ ºÐ¼®
Porter's Five Forces ºÐ¼®
±ÔÁ¦ »óȲ
±ÔÁ¦ ºÐ¼®
±ÔÁ¦±â°ü, Á¤ºÎ±â°ü, ±âŸ Á¶Á÷
ƯÇ㠺м®
¹«¿ª ºÐ¼®
HSÄÚµå : ¼Òȱâ¿ë ±â±¸
¼öÀÔ µ¥ÀÌÅÍ
¼öÃâ µ¥ÀÌÅÍ
°¡°Ý ºÐ¼®
»óȯ ºÐ¼®
ÁÖµÈ È¸ÀÇ¿Í À̺¥Æ®(2024³â-2025³â)
ÁÖ¿ä ÀÌÇØ°ü°èÀÚ¿Í ±¸¸Å ±âÁØ
¾ð¸ä ¿ä±¸ ¿ä±¸ÀÇ ºÐ¼®
ÃÖÁ¾ »ç¿ëÀÚÀÇ ±â´ë
»ýÅÂ°è ºÐ¼®
»ç·Ê ¿¬±¸ ºÐ¼®
°ø±Þ¸Á ºÐ¼®
ÅõÀÚ¿Í ÀÚ±ÝÁ¶´Þ ½Ã³ª¸®¿À
¼Òȱ⠰ü·Ã Á¦Ç° ½ÃÀå¿¡ ´ëÇÑ »ý¼ºÇü AI/AIÀÇ ¿µÇâ
Á¦6Àå ¼Òȱ⠰ü·Ã Á¦Ç° ½ÃÀå : µð¹ÙÀ̽ºº°
¼Ò°³
³»½Ã°æ µð¹ÙÀ̽º
À¯¿¬ÇÑ ³»½Ã°æ
°æ¼º ³»½Ã°æ
ĸ½¶ ³»½Ã°æ
±âŸ ³»½Ã°æ µð¹ÙÀ̽º
¾îºí·¹ÀÌ¼Ç µð¹ÙÀ̽º
°íÁÖÆÄ ¾îºí·¹ÀÌ¼Ç µð¹ÙÀ̽º
¸¶ÀÌÅ©·ÎÆÄ ¾îºí·¹ÀÌ¼Ç µð¹ÙÀ̽º
³Ãµ¿ ÀýÁ¦ ÀåÄ¡
·¹ÀÌÀú ¾îºí·¹ÀÌ¼Ç µð¹ÙÀ̽º
±âŸ ¾îºí·¹ÀÌ¼Ç µð¹ÙÀ̽º
¿îµ¿ °Ë»ç ÀåÄ¡
½Äµµ ³»¾Ð ÃøÁ¤ ÀåÄ¡
24½Ã°£ PH ÀÓÇÇ´ø½º °Ë»ç ÀåÄ¡
Ç×¹® Á÷Àå ³»¾Ð ÃøÁ¤ ÀåÄ¡
±âŸ ¿îµ¿ °Ë»ç ÀåÄ¡
»ý°Ë µð¹ÙÀ̽º
¹Ù´Ã »ý°Ë ±â±â
±âŸ »ý°Ë ±â±â
½ºÅÙÆ® µð¹ÙÀ̽º
´ã°ü ½ºÅÙÆ®
°áÀå ½ºÅÙÆ®
½ÊÀÌÁöÀå ½ºÅÙÆ®
ÃéÀå ½ºÅÙÆ®
½Äµµ ½ºÅÙÆ®
PH ¸ð´ÏÅ͸µ ÀåÄ¡
½Äµµ PH ¸ð´ÏÅ͸µ Ä«Å×ÅÍ
¹«¼± PH ¸ð´ÏÅ͸µ ĸ½¶
ÈÞ´ë¿ë PH ¸ð´ÏÅ͸µ ½Ã½ºÅÛ
±âŸ ¼Òȱ⠰ü·Ã µð¹ÙÀ̽º
À§³» dz¼±
¼Òȱâ¿ë Æ©ºê
Ä¡Áú Ä¡·á ÀåÄ¡
Á¦7Àå ¼Òȱ⠰ü·Ã Á¦Ç° ½ÃÀå : Áúȯº°
¼Ò°³
¼Òȱ⠾Ï
À§½Äµµ ¿ª·ùÁõ
°ú¹Î¼º Àå ÁõÈıº(IBS)
¿°Áõ¼º ÀåÁúȯ(IBD)
±âŸ Áúȯ
Á¦8Àå ¼Òȱ⠰ü·Ã Á¦Ç° ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°
¼Ò°³
º´¿ø
¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC),µ¶¸³°è ¼ö¼ú¼¾ÅÍ
Áø·á¼Ò
±âŸ ÃÖÁ¾ »ç¿ëÀÚ
Á¦9Àå ¼Òȱ⠰ü·Ã Á¦Ç° ½ÃÀå :Áö¿ªº°
¼Ò°³
ºÏ¹Ì
ºÏ¹ÌÀÇ °Å½Ã°æÁ¦ Àü¸Á
¹Ì±¹
ij³ª´Ù
À¯·´
À¯·´ÀÇ °Å½Ã °æÁ¦ Àü¸Á
µ¶ÀÏ
¿µ±¹
ÇÁ¶û½º
ÀÌÅ»¸®¾Æ
½ºÆäÀÎ
±âŸ À¯·´
¾Æ½Ã¾ÆÅÂÆò¾ç
¾Æ½Ã¾ÆÅÂÆò¾çÀÇ °Å½Ã °æÁ¦ Àü¸Á
ÀϺ»
Áß±¹
Àεµ
È£ÁÖ
Çѱ¹
±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
¶óƾ¾Æ¸Þ¸®Ä«
¶óƾ¾Æ¸Þ¸®Ä«ÀÇ °Å½Ã °æÁ¦ Àü¸Á
ºê¶óÁú
¸ß½ÃÄÚ
±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ °Å½Ã °æÁ¦ Àü¸Á
GCC ±¹°¡
±âŸ Áßµ¿?¾ÆÇÁ¸®Ä«
Á¦10Àå °æÀï ±¸µµ
°³¿ä
ÁÖ¿ä ±â¾÷ÀÇ Àü·«/À¯·Â ±â¾÷
¼öÀÍ ºÐ¼®(2021³â-2023³â)
½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
±â¾÷ Æò°¡ ¸ÅÆ®¸¯½º: ÁÖ¿ä ±â¾÷(2023³â)
±â¾÷ÀÇ Æò°¡ ¸ÅÆ®¸¯½º: ½ºÅ¸Æ®¾÷/Áß¼Ò±â¾÷(2023³â)
°æÀï ½Ã³ª¸®¿À
ºê·£µå/Á¦Ç° ºñ±³
±â¾÷ Æò°¡ ¹× À繫 ÁöÇ¥
Á¦11Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ
ÁÖ¿ä ±â¾÷
OLYMPUS CORPORATION
BOSTON SCIENTIFIC CORPORATION
MEDTRONIC PLC
STRYKER CORPORATION
COOK MEDICAL
FUJIFILM CORPORATION
CONMED CORPORATION
ETHICON(A JOHNSON & JOHNSON SUBSIDIARY)
MERIT MEDICAL SYSTEMS
STERIS PLC
KARL STORZ SE & CO. KG
±âŸ ±â¾÷
SHAILI ENDOSCOPY
TAEWOONG MEDICAL CO., LTD.
HOBBS MEDICAL, INC.
PENTAX MEDICAL
ERBE ELEKTROMEDIZIN
AMBU A/S
CAPSOVISION, INC.
INTROMEDIC, INC.
VIMEX ENDOSCOPY
TRIVITRON HEALTHCARE
MEDI-GLOBE CORPORATION
SONOSCAPE MEDICAL CORP.
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO. LTD.
MEDSPIRA
Á¦12Àå ºÎ·Ï
BJH
¿µ¹® ¸ñÂ÷
The global Gastroenterology/Gastrointestinal Products Market is projected to reach USD 19.7 billion by 2029 from USD 14.7 billion in 2024, at a CAGR of 6.1% from 2024 to 2029. The market for gastroenterology and gastrointestinal products is driven by several factors, such as the growing incidence of GI disorders, improvements in technology, aging populations, rising healthcare costs, increased awareness and screening initiatives, rising R&D spending, the need for personalized medicine, and economic expansion in emerging markets. The GI product industry is dynamic and ever-evolving due to the combined influence of these drivers.
Scope of the Report
Years Considered for the Study 2021-2029
Base Year 2023
Forecast Period 2024-2029
Units Considered Value (USD Billion)
Segments By Device, Disease, End User, and Region
Regions covered North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
"The endoscopy segment from the devices segment accounted for the largest share during the forecast period."
The Gastroenterology/Gastrointestinal product market is divided into Endoscopy, Ablations systems, Motility testing, Stenting devices, Ph monitoring, and other devices. The endoscopy segment accounted for the largest share during the forecast period. Endoscopic techniques enable the removal of polyps, tissue biopsies, stent implantation, and tumor ablation, among other therapeutic and diagnostic treatments. These developments support endoscopy's increasing use for a range of gastrointestinal disorders.
"The GERD segment in the diseases segment accounted for the largest share during the forecast period.."
The increasing prevalence of GERD, driven by lifestyle factors, obesity, aging populations, and enhanced diagnostic and treatment options, is significantly boosting the share of the gastroenterology market. As awareness grows and technological advancements continue, the demand for gastroenterological products and services is expected to rise, further driving market growth. As the global population ages, the incidence of GERD increases. Older adults are more susceptible to GERD due to changes in esophageal motility and the function of the lower esophageal sphincter.
"APAC is estimated to register the highest CAGR during the forecast period."
The Gastroenterology/Gastrointestinal Products Market is divided into Five regions- North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The Asia Pacific is witnessed to have the highest CAGR during the forecast period.. Many APAC countries, including Japan, South Korea, and China, are witnessing demographic shifts as their populations age. Older persons have a higher prevalence of diseases like GERD and complex healthcare needs.
Breakdown of supply-side primary interviews, by company type, designation, and region:
By Company Type: Tier 1 (20%), Tier 2 (45%), and Tier 3 (35%)
By Designation: C-level (30%), Director-level (20%), and Others (50%)
By Region: North America (35%), Europe (24%), Asia Pacific (25%), RoW(16%)
List of Companies Profiled in the Report
BOSTON SCIENTIFIC (U.S)
MEDTRONIC (U.S)
OLYMPUS CORPORATION (JAPAN)
STRYKER (U.S.)
GLOBUS MEDICAL (U.S.)
COOK MEDICAL (US)
ETHICON (SUBSIDIARY OF J&J)
FUJIFILM (JAPAN)
CONMED CORPORATION (US)
KARL STORZ (GERMANY)
Research Coverage
This report studies the Gastroenterology/Gastrointestinal Products Market based on devices, diseases, end-users and region. The report also analyses factors (such as drivers, restraints, opportunities and challenges) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micro markets concerning their growth trends, prospects, and contributions to the total Gastroenterology/Gastrointestinal Products Market. The report forecasts the revenue of the market segments to five major regions.
Reasons to Buy the Report
This report also includes.
Analysis of key drivers (increasing GI diseases, technological advancements) , restraints (Cost of the system), challenges(regulatory policies), and opportunities (Increase in the minimally invasive procedures) contributing to the growth of the Gastroenterology/Gastrointestinal Products Market.
Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, in the Gastroenterology/Gastrointestinal Products Market.
Market Development: Comprehensive information on the lucrative emerging markets by devices, diseases, end-users and region.
Market Diversification: Exhaustive information about the growing geographies, recent developments, and investments in the Gastroenterology/Gastrointestinal Products Market.
Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global Gastroenterology/Gastrointestinal Products Market..
TABLE OF CONTENTS
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.3.3 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
2.4 MARKET RANKING ANALYSIS
2.5 STUDY ASSUMPTIONS
2.6 RISK ASSESSMENT
2.7 LIMITATIONS
2.7.1 METHODOLOGY-RELATED LIMITATIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET OVERVIEW
4.2 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE AND REGION (2023)
4.3 GEOGRAPHIC SNAPSHOT OF GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rising prevalence of GI disorders
5.2.1.2 Technological advancements in gastroenterology products
5.2.1.3 Growing aging population
5.2.2 RESTRAINTS
5.2.2.1 Stringent regulatory policies for GI products
5.2.2.2 Increasing healthcare costs
5.2.2.3 Unfavorable healthcare reforms in US
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing preference for minimally invasive surgery
5.2.4 CHALLENGES
5.2.4.1 Changing regulatory landscape
5.2.4.2 Shortage of trained physicians and endoscopists
5.3 INDUSTRY TRENDS
5.4 TECHNOLOGY ANALYSIS
5.4.1 KEY TECHNOLOGIES
5.4.1.1 Capsule endoscopy
5.4.2 COMPLEMENTARY TECHNOLOGIES
5.4.2.1 Laboratory testing
5.4.3 ADJACENT TECHNOLOGIES
5.4.3.1 Robotic surgery systems
5.5 VALUE CHAIN ANALYSIS
5.6 PORTER'S FIVE FORCE ANALYSIS
5.6.1 THREAT OF NEW ENTRANTS
5.6.2 THREAT OF SUBSTITUTES
5.6.3 BARGAINING POWER OF SUPPLIERS
5.6.4 BARGAINING POWER OF BUYERS
5.6.5 INTENSITY OF COMPETITIVE RIVALRY
5.7 REGULATORY LANDSCAPE
5.7.1 REGULATORY ANALYSIS
5.7.1.1 North America
5.7.1.1.1 US
5.7.1.1.2 Canada
5.7.1.2 Europe
5.7.1.3 Asia Pacific
5.7.1.3.1 Japan
5.7.1.3.2 China
5.7.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.8 PATENT ANALYSIS
5.8.1 PATENT PUBLICATION TRENDS FOR GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS
5.8.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
5.9 TRADE ANALYSIS
5.9.1 HS CODES: GASTROENTEROLOGY/GASTROINTESTINAL INSTRUMENTS
5.9.2 IMPORT DATA
5.9.3 EXPORT DATA
5.10 PRICING ANALYSIS
5.11 REIMBURSEMENT ANALYSIS
5.12 KEY CONFERENCES & EVENTS, 2024-2025
5.13 KEY STAKEHOLDERS & BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.13.2 BUYING CRITERIA
5.14 UNMET NEEDS ANALYSIS
5.15 END-USER EXPECTATIONS
5.16 ECOSYSTEM ANALYSIS
5.17 CASE STUDY ANALYSIS
5.18 SUPPLY CHAIN ANALYSIS
5.19 INVESTMENT & FUNDING SCENARIO
5.20 IMPACT OF GEN AI/AI ON GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
6 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE
6.1 INTRODUCTION
6.2 ENDOSCOPY DEVICES
6.2.1 FLEXIBLE ENDOSCOPES
6.2.1.1 Advantages such as flexibility and ease of use to drive demand for flexible endoscopes
6.2.2 RIGID ENDOSCOPES
6.2.2.1 Ability of rigid endoscopes to provide vertical-axis images of internal organs to support market growth
6.2.3 CAPSULE ENDOSCOPES
6.2.3.1 Non-invasive nature of capsule endoscopes to drive adoption
6.2.4 OTHER ENDOSCOPY DEVICES
6.3 ABLATION DEVICES
6.3.1 RADIOFREQUENCY ABLATION DEVICES
6.3.1.1 Low cost of radiofrequency ablation to contribute to market growth
6.3.2 MICROWAVE ABLATION DEVICES
6.3.2.1 Advantages over RF ablation to ensure sustained demand for microwave ablation devices
6.3.3 CRYOABLATION DEVICES
6.3.3.1 Increasing cancer incidence to drive market for cryoablation devices
6.3.4 LASER ABLATION DEVICES
6.3.4.1 High efficacy and safety to drive adoption of laser/light ablation devices
6.3.5 OTHER ABLATION DEVICES
6.4 MOTILITY TESTING DEVICES
6.4.1 ESOPHAGEAL MANOMETRY DEVICES
6.4.1.1 Rising incidence of esophageal motility disorders to boost market growth
6.4.2 4-HOUR PH IMPEDANCE TESTING DEVICES
6.4.2.1 Ability to provide data useful for tailoring individualized treatment plans to favor market growth
6.4.3 ANORECTAL MANOMETRY DEVICES
6.4.3.1 Growing popularity of anorectal manometry devices for diagnosis of gastrointestinal problems to support market growth
6.4.4 OTHER MOTILITY TESTING DEVICES
6.5 BIOPSY DEVICES
6.5.1 NEEDLE BIOPSY DEVICES
6.5.1.1 Increasing screening of gastrointestinal diseases to aid growth
6.5.2 OTHER BIOPSY DEVICES
6.6 STENTING DEVICES
6.6.1 BILIARY STENTS
6.6.1.1 Increasing prevalence of bile duct cancer and chronic liver disease to drive growth
6.6.2 COLONIC STENTS
6.6.2.1 Rising demand for colonic stents due to high incidence of colorectal cancer to drive segmental growth
6.6.3 DUODENAL STENTS
6.6.3.1 Increasing prevalence of intestinal malignancy to boost adoption of duodenal stents
6.6.4 PANCREATIC STENTS
6.6.4.1 Rising number of ERCP and PTC procedures to drive market growth
6.6.5 ESOPHAGEAL STENTS
6.6.5.1 Increasing incidence of esophageal cancer to propel market growth
6.7 PH MONITORING DEVICES
6.7.1 ESOPHAGEAL PH MONITORING CATHETERS
6.7.1.1 Growing sedentary lifestyles to drive demand
6.7.2 WIRELESS PH MONITORING CAPSULES
6.7.2.1 Reduced risk of open surgeries to boost market
6.7.3 AMBULATORY PH MONITORING SYSTEMS
6.7.3.1 Convenience and accuracy of ambulatory pH monitoring to drive market
6.8 OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES
6.8.1 GASTRIC BALLOONS
6.8.1.1 Minimally invasive nature of gastric balloons to boost adoption
6.8.2 GASTROINTESTINAL TUBES
6.8.2.1 Rising incidence of diseases to drive need for gastrointestinal tubes
6.8.3 HEMORRHOID TREATMENT DEVICES
6.8.3.1 Rising cases of hemorrhoids to support market growth
7 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE
7.1 INTRODUCTION
7.2 GASTROINTESTINAL CANCERS
7.2.1 CHANGING DIETS AND GROWING PREVALENCE OF OBESITY TO BOOST MARKET GROWTH
7.3 GASTROESOPHAGEAL REFLUX DISEASE
7.3.1 GROWING INCIDENCE OF GERD TO DRIVE MARKET GROWTH
7.4 IRRITABLE BOWEL SYNDROME (IBS)
7.4.1 GROWING IBS DISEASE BURDEN TO DRIVE DEMAND FOR GASTROINTESTINAL PRODUCTS
7.5 INFLAMMATORY BOWEL DISEASE (IBD)
7.5.1 GROWING USE OF CAPSULE ENDOSCOPES IN TREATING IBD TO FAVOR MARKET GROWTH
7.6 OTHER DISEASES
8 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER
8.1 INTRODUCTION
8.2 HOSPITALS
8.2.1 HIGH VOLUME OF MINIMALLY INVASIVE PROCEDURES TO DRIVE DEMAND FOR GASTROINTESTINAL PROCEDURES IN HOSPITALS
8.3 AMBULATORY SURGICAL CENTERS & INDEPENDENT SURGICAL CENTERS
8.3.1 LOWER COSTS AND SHORTER PATIENT STAYS TO DRIVE MARKET GROWTH
8.4 CLINICS
8.4.1 GROWING NEED FOR CLINICAL SCREENING TO DIAGNOSE GASTROINTESTINAL DISEASES TO BOOST MARKET
8.5 OTHER END USERS
9 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
9.2.2 US
9.2.2.1 US to dominate North American market during forecast period
9.2.3 CANADA
9.2.3.1 Increased availability of funding and presence of research institutes to propel market
9.3 EUROPE
9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
9.3.2 GERMANY
9.3.2.1 Favorable reimbursement scenario and increased geriatric population to aid market growth
9.3.3 UK
9.3.3.1 Rising investments by hospitals in new and advanced gastroenterology/gastrointestinal products to augment market growth
9.3.4 FRANCE
9.3.4.1 Increase in health expenditure and high prevalence of cancer to stimulate market growth
9.3.5 ITALY
9.3.5.1 High per capita income and improved healthcare system to drive market
9.3.6 SPAIN
9.3.6.1 Growing prevalence of cardiovascular diseases to boost market growth
9.3.7 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
9.4.2 JAPAN
9.4.2.1 Favorable medical device reimbursement policies and public health insurance schemes to aid market growth
9.4.3 CHINA
9.4.3.1 Increasing geriatric population and increase in domestic manufacturers for gastrointestinal products to support growth
9.4.4 INDIA
9.4.4.1 Increasing incidence of diseases like diabetes to enhance market growth
9.4.5 AUSTRALIA
9.4.5.1 High incidence of cancer to propel market growth
9.4.6 SOUTH KOREA
9.4.6.1 Rapidly aging population and high incidence of gastrointestinal diseases to aid market growth
9.4.7 REST OF ASIA PACIFIC
9.5 LATIN AMERICA
9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
9.5.2 BRAZIL
9.5.2.1 Increase in private healthcare investments and rise in medical tourism to aid market growth
9.5.3 MEXICO
9.5.3.1 Increased government investment in healthcare infrastructure and technological advancements to aid market growth
9.5.4 REST OF LATIN AMERICA
9.6 MIDDLE EAST & AFRICA
9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
9.6.2 GCC COUNTRIES
9.6.2.1 Increasing investment in healthcare infrastructure and growing medical tourism to propel market growth
9.6.3 REST OF MIDDLE EAST & AFRICA
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGY/RIGHT TO WIN
10.3 REVENUE ANALYSIS, 2021-2023
10.4 MARKET SHARE ANALYSIS, 2023
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
10.5.5.1 Company footprint
10.5.5.2 Disease footprint
10.5.5.3 End-user footprint
10.5.5.4 Region footprint
10.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023
10.6.1 PROGRESSIVE COMPANIES
10.6.2 RESPONSIVE COMPANIES
10.6.3 DYNAMIC COMPANIES
10.6.4 STARTING BLOCKS
10.6.5 COMPETITIVE BENCHMARKING: START-UPS/SMES, 2023
10.7 COMPETITIVE SCENARIO
10.7.1 PRODUCT LAUNCHES & APPROVALS
10.7.2 DEALS
10.7.3 EXPANSIONS
10.8 BRAND/PRODUCT COMPARISON
10.9 COMPANY VALUATION & FINANCIAL METRICS
10.9.1 FINANCIAL METRICS
10.9.2 COMPANY VALUATION
11 COMPANY PROFILES
11.1 KEY PLAYERS
11.1.1 OLYMPUS CORPORATION
11.1.1.1 Business overview
11.1.1.2 Products offered
11.1.1.3 Recent developments
11.1.1.3.1 Product launches & approvals
11.1.1.3.2 Deals
11.1.1.3.3 Expansions
11.1.1.4 MnM view
11.1.1.4.1 Right to win
11.1.1.4.2 Strategic choices
11.1.1.4.3 Weaknesses & competitive threats
11.1.2 BOSTON SCIENTIFIC CORPORATION
11.1.2.1 Business overview
11.1.2.2 Products offered
11.1.2.3 Recent developments
11.1.2.3.1 Product launches & approvals
11.1.2.3.2 Deals
11.1.2.4 MnM view
11.1.2.4.1 Right to win
11.1.2.4.2 Strategic choices
11.1.2.4.3 Weaknesses & competitive threats
11.1.3 MEDTRONIC PLC
11.1.3.1 Business overview
11.1.3.2 Products offered
11.1.3.3 Recent developments
11.1.3.3.1 Product approvals
11.1.3.3.2 Deals
11.1.3.4 MnM view
11.1.3.4.1 Right to win
11.1.3.4.2 Strategic choices
11.1.3.4.3 Weaknesses & competitive threats
11.1.4 STRYKER CORPORATION
11.1.4.1 Business overview
11.1.4.2 Products offered
11.1.4.3 Recent developments
11.1.4.3.1 Product approvals
11.1.4.3.2 Deals
11.1.4.3.3 Expansions
11.1.4.4 MnM view
11.1.4.4.1 Right to win
11.1.4.4.2 Strategic choices
11.1.4.4.3 Weaknesses & competitive threats
11.1.5 COOK MEDICAL
11.1.5.1 Business overview
11.1.5.2 Products offered
11.1.5.3 Recent developments
11.1.5.3.1 Product launches & approvals
11.1.5.3.2 Deals
11.1.5.4 MnM view
11.1.5.4.1 Right to win
11.1.5.4.2 Strategic choices
11.1.5.4.3 Weaknesses & competitive threats
11.1.6 FUJIFILM CORPORATION
11.1.6.1 Business overview
11.1.6.2 Products offered
11.1.6.3 Recent developments
11.1.6.3.1 Product launches & approvals
11.1.6.3.2 Other developments
11.1.7 CONMED CORPORATION
11.1.7.1 Business overview
11.1.7.2 Products offered
11.1.8 ETHICON (A JOHNSON & JOHNSON SUBSIDIARY)
11.1.8.1 Business overview
11.1.8.2 Products offered
11.1.8.3 Recent developments
11.1.8.3.1 Product launches & approvals
11.1.9 MERIT MEDICAL SYSTEMS
11.1.9.1 Business overview
11.1.9.2 Products offered
11.1.9.3 Recent developments
11.1.9.3.1 Product launches
11.1.10 STERIS PLC
11.1.10.1 Business overview
11.1.10.2 Products offered
11.1.11 KARL STORZ SE & CO. KG
11.1.11.1 Business overview
11.1.11.2 Products offered
11.1.11.3 Recent developments
11.2 OTHER PLAYERS
11.2.1 SHAILI ENDOSCOPY
11.2.2 TAEWOONG MEDICAL CO., LTD.
11.2.3 HOBBS MEDICAL, INC.
11.2.4 PENTAX MEDICAL
11.2.5 ERBE ELEKTROMEDIZIN
11.2.6 AMBU A/S
11.2.7 CAPSOVISION, INC.
11.2.8 INTROMEDIC, INC.
11.2.9 VIMEX ENDOSCOPY
11.2.10 TRIVITRON HEALTHCARE
11.2.11 MEDI-GLOBE CORPORATION
11.2.12 SONOSCAPE MEDICAL CORP.
11.2.13 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO. LTD.
11.2.14 MEDSPIRA
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
°ü·ÃÀÚ·á